Total ceramide content was higher in human NASH liver, and a separate study reported an increase of Cer d18:1/16:0 whereas Cer d18:1/24:0 declined [35, 36]. The gene discussed is CBLN1; the disease is metabolic dysfunction-associated steatohepatitis.